Structure and Organization
IMM Associate Members
Universidade de Lisboa
Faculdade de Medicina da Universidade de Lisboa
Hospital de Santa Maria
Fundação da Universidade de Lisboa
Associação para a Investigação e o Desenvolvimento da Faculdade de Medicina
Board of Trustees
Composed by representatives of the Associate Members and meets to analyse the scientific and finance report and to approve the plan of activities and budget for the next year.
Board of Directors
Responsible for the management of the Institute according to the plans approved by the Trustees and elected by the Trustees.
João Lobo Antunes, MD, PhD (President)
Maria Carmo-Fonseca, MD, PhD (Executive Director)
José Moniz Pereira, PhD (Vice-President)
Patrícia da Cunha (Secretary)
Contacts: pcucio at fm.ul.pt | (+351) 217999411
Composed by the Directors, the Research Programme Coordinators and the Directors of Faculdade de Medicina and Hospital de Santa Maria. It meets to define scientific strategies and actions, administrative organization plans and budgetary priorities.
Council of Scientists
Composed by all Principal Investigators. It meets to discuss the scientific strategies and plan of actions proposed by the Board of Directors. This Council elects two Representatives to participate in the meetings of the Board of Trustees.
Scientific Advisory Committees
Undertake periodic evaluations to the IMM specific programmes and include international experts of scientific fields analysed.
Neurosciences Programme | 2010
Michael Spyer, University College London, UK
Christine Gall, University of California, USA
Charles Warlow, Western General Hospital, Edinburgh, UK
Reinhard Dengler, Medizinische Hochschule, Hannover, Germany
Immunology and Infectious Diseases Programme | 2009
Anne O’Garra, National Institute for Medical Research, UK
Alain Fischer, Hôpital Necker Enfants Malade, Paris, France
William Paul, National Institute of Allergy and Infectious Diseases, NIH, USA
Philippe Sansonetti, Institut Pasteur, France
Antonio Freitas, Institut Pasteur, France
Cell and Developmental Biology Programme | 2006
Philip Ingham, University of Shefield/Institute of Molecular and Cell Biology, Singapore
Frank Grosveld, Erasmus University, Rotterdam, the Netherlands
Outi Hovatta, Karolinska Institut, Stockholm, Sweden
Iain Mattaj, European Molecular Biology Laboratory, Heidelberg, Germany
Axel Pries, Department of Physiology, Charité-Berlin, Germany